Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Multiple Myeloma 12Recurrence 9Neoplasms 8Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Colorectal Neoplasms 7Pancreatic Neoplasms 6Lymphoma, B-Cell 6Carcinoma, Hepatocellular 6Breast Neoplasms 6Sarcoma 5Prostatic Neoplasms 5Lymphoma 5Burkitt Lymphoma 5Neoplasms, Plasma Cell 4Myasthenia Gravis 4Lung Neoplasms 4Glioblastoma 4Brain Neoplasms 4Stomach Neoplasms 3Solid Tumor 3Pituitary Neoplasms 3Ovarian Neoplasms 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3

Interventions

osimertinib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × Neoplastic Cells, Circulating × Clear all
NCT06557096 2024-08-16

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

Second Affiliated Hospital of Nanchang University

Phase EARLY_PHASE1 Not yet recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡